For drug registration in Taiwan, safety requirements include comprehensive preclinical and clinical trials to assess toxicity and efficacy, ensuring the drug poses minimal risk to patients. The TFDA also mandates pharmacovigilance plans and post-market surveillance to monitor adverse effects. Compliance with Good... Read More
Vaccines in Taiwan are registered through the TFDA by submitting clinical trial data, manufacturing details, and evidence of Good Manufacturing Practice (GMP) compliance. The process includes assessments of safety, efficacy, and immunogenicity. Accelerated pathways may apply for urgent needs, such as pandemic... Read More
In Taiwan’s regulatory framework, a biologic refers to a product derived from living organisms, such as proteins, vaccines, blood products, or monoclonal antibodies. These products are more complex than chemical drugs and require stringent clinical and quality data, including immunogenicity assessments and... Read More
Generic drugs in Taiwan are registered through an abbreviated review process, focusing on bioequivalence studies to demonstrate that they are as effective and safe as the original product. Applicants must submit quality control data and ensure Good Manufacturing Practice (GMP) compliance. The... Read More
Manufacturing facilities involved in Taiwan’s drug registration must comply with Good Manufacturing Practice (GMP) standards. This includes maintaining stringent quality control systems, ensuring proper equipment and facility hygiene, and documenting production processes. The TFDA inspects these facilities to verify compliance, and non-compliance... Read More
On-site inspections are critical in Taiwan’s drug registration, as they allow the TFDA to verify Good Manufacturing Practice (GMP) compliance. These inspections assess the quality control processes, production facilities, and documentation to ensure the drug meets regulatory standards. Successful inspections are essential... Read More
Good Manufacturing Practice (GMP) ensures that drugs registered in Taiwan meet consistent quality, safety, and efficacy standards. The Taiwan FDA (TFDA) requires GMP compliance throughout the manufacturing process, including facility inspections and quality control systems. GMP verification is essential for drug approval,... Read More
The Taiwan FDA (TFDA) reviews a New Drug Application (NDA) by evaluating clinical, manufacturing, and quality data to ensure the drug’s safety, efficacy, and quality. The review process involves technical assessments, Good Manufacturing Practices (GMP) verification, and may include consultations or requests... Read More
A pre-submission meeting with the Taiwan FDA (TFDA) helps applicants clarify regulatory requirements, address potential issues with their application, and ensure it aligns with TFDA guidelines. This meeting reduces the likelihood of delays or rejections by discussing data expectations, format requirements, and... Read More
Yes, Taiwan allows the submission of foreign clinical data for drug registration, but the Taiwan FDA (TFDA) often requires bridging studies to confirm that the results are applicable to the Taiwanese population. These studies assess potential differences in safety, efficacy, or pharmacokinetics... Read More